Trials / Completed
CompletedNCT06630897
Art and Science of Human Flourishing Microsupport Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 186 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether providing small amounts of digital support impacts students in the Art and Science of Human Flourishing (ASHF) course. Approximately 300 participants will be enrolled and can expect to be on study for up to 4 months.
Detailed description
Participants will be currently enrolled students in the ASHF course. Students will complete measures at baseline, daily during the 1-month intervention period, at post-treatment, and 3 months later. During the 1-month intervention period, half of the participants will be randomized to receive small amounts of digital support in the form of text messages. Context (from the course website): The Art and Science of Human Flourishing course is taught in tandem with the Healthy Minds Program (HMP) app. The overall framework of the ASHF course largely aligns with the HMP app and is composed of the following modules and sub-themes which are covered throughout the course of a 15-week semester: Foundations: Flourishing, Transformation, Resilience * Awareness: Focus, Emotions, Mindfulness * Connection: Interdependence, Compassion, Diversity * Wisdom: Identity, Values, Gratitude * Integration: Courage, Community Small amounts of digital support will be tested on half the participants. Primary Outcomes for measuring the effect of this support will be the PROMIS Depression and Anxiety Measures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Text Messages | small amounts of digital support will be in the form of text messages |
Timeline
- Start date
- 2024-10-07
- Primary completion
- 2025-03-05
- Completion
- 2025-03-05
- First posted
- 2024-10-08
- Last updated
- 2025-03-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06630897. Inclusion in this directory is not an endorsement.